COMPARE, an ultra-fast and robust suite for multiparametric screening, identifies phenotypic drug responses in acute myeloid leukemia

Abstract

Multiparametric phenotypic screening of cells, for example assessing their responses to small molecules or knockdown/knockout of specific genes, is a powerful approach to understanding cellular systems and identifying potential new therapeutic strategies. However, automated tools for analyzing similarities and differences between a large number of tested conditions have not been readily available. Methods designed for clustering cells cannot identify differences between samples effectively. We introduce O_SCPLOWCOMPAC_SCPLOWRO_SCPLOWEC_SCPLOW for ultra-fast and robust analysis of multiparametric high-throughput screening. Applying a mass-aware gridding algorithm using hypercubes, O_SCPLOWCOMPAC_SCPLOWRO_SCPLOWEC_SCPLOW performs automatic and effective similarity comparison for hundreds to thousands of tests and provides information about the treatment effect. Particularly for screening data, O_SCPLOWCOMPAC_SCPLOWRO_SCPLOWEC_SCPLOW is equipped with modules to remove various sources of bias. Benchmarking tests show that O_SCPLOWCOMPAC_SCPLOWRO_SCPLOWEC_SCPLOW can circumvent batch effects and perform a similarity analysis substantially faster than conventional analysis tools. Applying O_SCPLOWCOMPAC_SCPLOWRO_SCPLOWEC_SCPLOW to high-throughput flow cytometry screening data, we were able to distinguish subtle phenotypic drug responses in a human sample and a genetically engineered mouse model with acute myeloid leukemia (AML). O_SCPLOWCOMPAC_SCPLOWRO_SCPLOWEC_SCPLOW revealed groups of drugs with similar responses even though their mechanisms are distinct from each other. In another screening, O_SCPLOWCOMPAC_SCPLOWRO_SCPLOWEC_SCPLOW effectively circumvented batch effects and grouped samples from AML and myelodysplastic syndrome (MDS) patients using clinical flow cytometry data.